Why Pharmaceutical Grade Cannabinoids Are Needed for Clinical Trials Recently, Tilray made big news announcing that they would be importing Canadian cannabis into the USA for clinical trials. This ruffled some feathers in the US cannabis industry, who operate under state legal programs while the US Federal law insists that cannabis is a highly dangerous and [...]
CBD Oil vs Hemp Oil vs Hemp Seed Oil - What's the difference? CBD Oil, Hemp Oil and Hemp Seed Oil are related products which can be produced from the Hemp plan, Cannabis Sativa. Consumers and health professionals often get confused by the differences between the different products hemp oil products. Hemp Seed Oil Hemp Seed Oil [...]
Pharma Grade CBD Products to be Rescheduled to Schedule V Pharma Grade CBD Products such as Epidiolex will be Schedule V - comparable to codeine-containing cough syrups - indicating a low potential for abuse and effectiveness as a therapeutic drug. The Drug Enforcement Agency published a notification on the FDA CBD rescheduling in the Federal Register. "With [...]
Hemp industry turns to Pharma tech to meet growing demand for Cannabidiol Rhizo Sciences partners with Thar Process to extract CBD from hemp at industrial scale Seattle, May 10, 2018 The hemp industry is undergoing a renaissance due to an explosion of interest in Cannabidiol, (aka CBD) but it’s struggling to keep up with [...]
Medical Cannabis is Going Global The medical cannabis industry is booming, growing faster than any industry segment since dot.com boom. It sounds like an investor's dream: Fast moving, high growth, high return, and a queue of institutional investors waiting on the sidelines to pour in capital following legalisation, including big pharma, big food, big alcohol, and [...]
Rhizo Sciences is a collective team of industry professionals from Seattle specializing in extraction systems...
